Collaborations of physicians and researchers with industry can provide valuable benefits to
society, particularly in the translation of basic scientific discoveries to new therapies and …

Background: Increasing attention has been given to the transparency of potential conflicts of
interest in clinical medicine and biomedical sciences, particularly in journal publishing and …

Background There is an emerging literature on the existence and effect of industry
relationships on physician and researcher behavior. Much less is known, however, about …

Background The effects of clinical-trial funding on the interpretation of trial results are poorly
understood. We examined how such support affects physicians' reactions to trials with a …

Three recent systematic reviews have shown that pharmaceutical industry funding of clinical
trials is strongly associated with pro-industry results. This article builds on those analyses …

Abstract Background The World Health Organization (WHO), like many other organisations
around the world, has recognised the need to use more rigorous processes to ensure that …

Context Disclosure of conflicts of interest (COIs) from pharmaceutical industry study funding
and author-industry financial relationships is sometimes recommended for randomized …

One of the hallmarks of a trustworthy clinical guideline or guidance statement is a
comprehensive process for disclosure of interests (DOI) and management of conflicts of …

Background Despite increased demand for disclosure of physician and researcher financial
ties (FTs) to industry, little is known about patients', research participants', or journal readers' …

Objective: To identify characteristics of submitted manuscripts that are associated with
acceptance for publication by major biomedical journals. Design, setting and participants: A …